Exemption and Exclusion From Certain Requirements of the Drug Supply Chain Security Act for the Distribution of FDA-Approved Naloxone Products During the Opioid Public Health Emergency Guidance for Industry

Articles and Publications

FDA issued this guidance to support efforts to facilitate public availability of and access to FDA-approved naloxone products for emergency treatment of opioid overdoses, particularly in underserved communities. The FDA is issuing this guidance to help address some of the obstacles to naloxone access identified during community engagements. Further, the guidance supports the FDA Overdose Prevention Framework’s priority to expand availability and access to naloxone.

Link to Resource

Related Resources

Hope Central

Hope in Action for Child Welfare

This report from the Oklahoma Department of Human Services details how Hope Science was integrated into their work.

Pre-Recorded Webinar: UVM CORA Community Rounds: Strategies for Distributing Naloxone to Rural Communities

“Strategies for Distributing Naloxone to Rural Communities" provides evidence based practices for rural areas to increase distribution of naloxone in rural communities. Discusses naloxone vending machines…

From SAMHSA: Rural Recovery Innovations

SAMHSA's new fact sheet serves as a resource regarding behavioral health needs in rural areas. It offers promising solutions to improve behavioral health outcomes in these communities.